350+
Clinical trials completed in diabetes, NASH & obesity
17
Contributions to 17 approved metabolic drugs and devices
19+
Years as the leading clinical research provider for metabolic diseases
DIABETES
Unparalleled clinical research expertise in type 1 and type 2 diabetes
NASH
(Nonalcoholic Steatohepatitis)
Accelerating drug development and advancing biomarker research for NAFLD and NASH
OBESITY
Advancing obesity drug development through unparalleled metabolic expertise
